Axel Bex, Johannes Cornelis van der Mijn, Niels Graafland, Johannes V. van Thienen, Sofie Wilgenhof, Brunolf Lagerveld, Patricia Zondervan, Reindert Jeroen A. Van Moorselaar, Mark Kockx, Pieter-Jan Van Dam, Pieter Mestdagh, Bernadett Emma Szabados, Christian U. Blank, Thomas Powles, John Haanen. "Exploratory analysis from NEOAVAX, a neoadjuvant trial of avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4509